Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1992-10-06
1993-10-05
Berch, Mark L.
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
540362, 540357, 540359, 540360, C07D20508, C07D20509, C07D24700, A61K 31395
Patent
active
052506770
ABSTRACT:
The present invention relates to new 3-guanidinoalkyl-2-azetidinones of the formula ##STR1## wherein: U and W can be the same or different and are selected from the group consisting of hydrogen and an amino protecting group;
REFERENCES:
patent: 4623645 (1986-11-01), Doherty et al.
patent: 4637999 (1987-01-01), Doherty et al.
patent: 4680391 (1987-07-01), Firestone et al.
patent: 4699904 (1987-10-01), Doherty et al.
patent: 4717722 (1988-01-01), Doherty et al.
patent: 4845088 (1989-07-01), Doherty et al.
Doherty, et al., Cephalosporin Antibiotics can be Modified to Inhibit Human Leukecyte Elastase, Nature, 322, p. 192 (1986).
Gianfranco, C., et al. Stereocontrolled Total Synthesis of Chiral Building Block (3S,4R)-3-[(R)-1-Hydroethyl]-4-Acetyloxy-Azetidin-2-One; A Useful Synthon for the Synthesis of (+)-Thienamycin, Carbapenems and Penems. Tetrahedron Letters, 26, No. 7, pp. 937-940, (1985).
Berch Mark L.
Bristol--Myers Squibb Company
Han William T.
LandOfFree
Azetidin-2-one derivatives as serine protease inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azetidin-2-one derivatives as serine protease inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azetidin-2-one derivatives as serine protease inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1005257